Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients w...
Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with NHL and CLLПодробнее
CAR T-Cell Therapy: The Patient PerspectiveПодробнее
Jeremy Abramson, MD: A Doctor’s Perspective of CAR T-Cell TherapyПодробнее
CAR T-cell therapy: the patient's perspectiveПодробнее
Chimeric Antigen Receptor T-Cell Therapy in ALLПодробнее
CAR-T cell therapy for adult ALLПодробнее
Evaluating the cost and benefits of CAR-T therapyПодробнее
CAR T-Cell Therapy: It's Role after Transplant 2021Подробнее
Clinical data for CD19-directed CAR T-cell products in ALLПодробнее
Outcomes in patients treated w/ chimeric antigen receptor T-cell therapy admitted to intensive careПодробнее
CAR T-Cell Therapy Clinical TrialsПодробнее
Panel discussion on immune therapies for lymphoma - CAR T-cell therapy and the question of cureПодробнее
Patient perspectives of CAR T-cell therapyПодробнее
CAR T-Cell Therapy: Real-World ApplicationsПодробнее
Nursing & CAR T-cell therapy: challenges and rolesПодробнее
Role of CAR T-Cell Therapy in Relapsed/Refractory ALLПодробнее
CAR T-Cell Therapy and the Patient ExperienceПодробнее
What is CAR T-cell therapy and how does it work?Подробнее
CAR-T therapy in multiple myeloma: recent updates, clinical trials and future outlooksПодробнее
